AL 20/120mg, blister of 24 tab., >35 kg

STD DORAARLU4T1

Valid Article

Former Code(s): DORAALBF24A DORAZFR0506
6.5.3.1 - For curative treatment
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BF01
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

ARTEMETHER (A)/ LUMEFANTRINE (L)

Therapeutic Action

Fixed-dose combination (FDC) of two antimalarials

Indications

Treatment of uncomplicated P. falciparum malaria

Completion treatment following parenteral therapy for severe malaria

Instructions for use

Blister presentation for 3-days treatment.

5 different presentations for 4 categories of weight:

  • infants 5-14kg: blister of 6 disp. tab
  • children 15-2 kg: blister of 12 disp. tab.
  • adolescents 25-34 kg: blister of 18 tab.
  • adults > 35 kg: blister of 24 tab. (20/120 mg) or blister of 6 tab (80/480mg).

Presentations must be ordered for all 4 weight categories.

In adults, the 80/480 mg formulation allows for better compliance as the number of tablets to be taken is less than with the 20/120 mg formulation (1 tab 2x/day instead of 4 tabs 2x/day).

The quantity to be ordered is calculated per blister (= one treatment), not per tablet.

Storage

  • Below 25°C
  • Shelf life: 24 or 36 months depending on the manufacturer